Sonus raises $5 million equity finance:
This article was originally published in Clinica
Executive Summary
Sonus Pharmaceuticals, which is developing drug delivery and a synthetic blood substitute product, has had a private placement of 1.7 million shares, raising $4.9 million in gross proceeds. The company, based in Bothell, Washington, said that the funds strengthen cash reserves in order to advance the development of its drug delivery products.